Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.4K

Recent developments in radiosensitization.

Justin Linam1, Li-Xi Yang2

  • 1Department of Radiation Oncology, California Pacific Medical Center, San Francisco, CA, U.S.A.

Anticancer Research
|May 13, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Toxicity of a Highly Potent Camptothecin Analogue: A Pilot Study with Glioblastoma Multiforme Cells.

Anticancer research·2016
Same author

A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells.

PloS one·2015
Same author

Radiation-associated Cardiac Injury.

Anticancer research·2015
Same author

Cardiotoxicity of molecular-targeted drug therapy.

Anticancer research·2014
Same author

Radioprotectants to reduce the risk of radiation-induced carcinogenesis.

International journal of radiation biology·2013
Same author

Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.

Anticancer research·2013
Same journal

Corrigendum.

Anticancer research·2026
Same journal

Geographic Variation in Stage at Diagnosis of Skin Cancer in the United States: A National Cancer Database Analysis.

Anticancer research·2026
Same journal

Anti-tumor Effects of Loureirin A Treatment in Colorectal Cancer Cells <i>via</i> Inhibition of AKT Phosphorylation.

Anticancer research·2026
Same journal

Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab <i>vs</i>. Sunitinib) for Advanced Renal Cell Carcinoma.

Anticancer research·2026
Same journal

Pulsed Electromagnetic Field Increases Doxorubicin-induced Mitotic Slippage in MDA-MB-231 Breast Cancer Cells.

Anticancer research·2026
Same journal

Geographic Disparities in Socioeconomic Factors and Advanced-stage Presentation in Rectosigmoid Cancer: A National Cancer Database Analysis.

Anticancer research·2026
See all related articles

Researchers are exploring novel radiosensitizing compounds to improve cancer treatment efficacy and minimize side effects. These agents target cancer cells, enhancing radiation damage while protecting normal tissues, with promising pre-clinical results.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Pharmacology

Background:

  • Radiation therapy is a cornerstone of cancer treatment for local tumor control.
  • Technological advancements enable precise radiation delivery, minimizing damage to healthy tissues.
  • Developing radiosensitizing agents is crucial for enhancing treatment efficacy and reducing side effects.

Purpose of the Study:

  • To review recent advancements in radiosensitization research for cancer therapy.
  • To highlight promising compounds that increase cancer cell sensitivity to ionizing radiation.
  • To explore novel strategies for improving radiation therapy outcomes.

Main Methods:

  • Review of current scientific literature on radiosensitization.
  • Analysis of compounds targeting hypoxia, topoisomerases, microtubules, and caspases.
Keywords:
Radiosensitivityhypoxiaradiosensitizersradiotherapyreactive oxygen speciesreviewtopoisomerase

More Related Videos

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
04:53

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

Published on: August 25, 2022

2.3K
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.5K

Related Experiment Videos

Last Updated: Apr 12, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.4K
Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
04:53

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

Published on: August 25, 2022

2.3K
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.5K
  • Evaluation of pre-clinical trial data for radiosensitizing agents.

    • Main Results:

    • Several compounds demonstrate significant potential in pre-clinical studies.
    • Mechanisms include modulating tumor hypoxia, inhibiting key enzymes, and disrupting cellular processes.
    • Compounds show promise in enhancing radiation-induced cancer cell death.

    Conclusions:

    • Radiosensitizing agents offer a promising approach to augment radiation therapy.
    • Further clinical trials are necessary to establish safety, efficacy, and practicality.
    • Future research should focus on translating pre-clinical findings into clinical applications.